RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q2 2013 (Next →)

Filing Date: Aug 14, 2013

Total Value: $754M (100.0% shares, 0.0% debt)

Holdings (29)

ACAD ACADIA PHARMACEUTICALS INC 15.7%
Value $119M Shares 6,529,810 Share Price $18.15 * Est. Cost/Share $13.77 Unrealized @ Report Date 0.0%
ACAD ACADIA PHARMACEUTICALS INC 12.0%
Value $90.75M Shares 5,000,000 Share Price $18.15 * Est. Cost/Share $13.77 Unrealized @ Report Date 0.0%
— ACHILLION PHARMACEUTICALS IN 8.1%
Value $60.98M Shares 7,455,202 Share Price $8.18 Est. Cost/Share $8.18 Unrealized @ Report Date —
— KERYX BIOPHARMACEUTICALS INC 5.6%
Value $42.27M Shares 5,659,285 Share Price $7.47 Est. Cost/Share $7.47 Unrealized @ Report Date —
SGMO SANGAMO BIOSCIENCES INC 5.6%
Value $41.92M Shares 5,368,094 Share Price $7.81 * Est. Cost/Share $8.72 Unrealized @ Report Date 0.0%
— DYAX CORP 5.0%
Value $37.74M Shares 10,908,379 Share Price $3.46 Est. Cost/Share $3.46 Unrealized @ Report Date —
— NEWLINK GENETICS CORP 4.8%
Value $36.29M Shares 1,840,294 Share Price $19.72 Est. Cost/Share $19.72 Unrealized @ Report Date —
— NOVAVAX INC 4.7%
Value $35.2M Shares 17,170,801 Share Price $2.05 Est. Cost/Share $2.05 Unrealized @ Report Date —
— THERAPEUTICSMD INC 4.5%
Value $34.13M Shares 11,262,608 Share Price $3.03 Est. Cost/Share $3.03 Unrealized @ Report Date —
INSM INSMED INC 3.9%
Value $29.1M Shares 2,433,319 Share Price $11.96 * Est. Cost/Share $10.22 Unrealized @ Report Date 0.0%
— DERMA SCIENCES INC 3.5%
Value $26.63M Shares 1,994,876 Share Price $13.35 Est. Cost/Share $13.35 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 3.2%
Value $24.45M Shares 4,716,296 Share Price $5.19 Est. Cost/Share $5.19 Unrealized @ Report Date —
— XOMA CORP DEL 3.2%
Value $24.32M Shares 6,698,558 Share Price $3.63 Est. Cost/Share $3.63 Unrealized @ Report Date —
SGMO SANGAMO BIOSCIENCES INC 3.1%
Value $23.43M Shares 3,000,000 Share Price $7.81 * Est. Cost/Share $8.72 Unrealized @ Report Date 0.0%
— HYPERION THERAPEUTICS INC 2.6%
Value $19.86M Shares 902,858 Share Price $22.00 Est. Cost/Share $22.00 Unrealized @ Report Date —
— RECEPTOS INC 2.6%
Value $19.39M Shares 975,000 Share Price $19.89 Est. Cost/Share $19.89 Unrealized @ Report Date —
— ACHILLION PHARMACEUTICALS IN 2.2%
Value $16.36M Shares 2,000,000 Share Price $8.18 Est. Cost/Share $8.18 Unrealized @ Report Date —
OMER OMEROS CORP 2.0%
Value $14.88M Shares 2,953,004 Share Price $5.04 * Est. Cost/Share $4.61 Unrealized @ Report Date 0.0%
— ONCOGENEX PHARMACEUTICALS IN 1.1%
Value $8.461M Shares 863,332 Share Price $9.80 Est. Cost/Share $9.80 Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 1.0%
Value $7.724M Shares 436,145 Share Price $17.71 * Est. Cost/Share $19.50 Unrealized @ Report Date 0.0%
— KERYX BIOPHARMACEUTICALS INC 1.0%
Value $7.47M Shares 1,000,000 Share Price $7.47 Est. Cost/Share $7.47 Unrealized @ Report Date —
— ENZO BIOCHEM INC 0.9%
Value $6.964M Shares 3,348,029 Share Price $2.08 Est. Cost/Share $2.08 Unrealized @ Report Date —
— DYNAVAX TECHNOLOGIES CORP 0.9%
Value $6.6M Shares 6,000,000 Share Price $1.10 Est. Cost/Share $1.10 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 0.9%
Value $6.427M Shares 497,807 Share Price $12.91 * Est. Cost/Share $9.30 Unrealized @ Report Date 0.0%
— ARROWHEAD RESH CORP 0.8%
Value $6.23M Shares 3,114,755 Share Price $2.00 Est. Cost/Share $2.00 Unrealized @ Report Date —
— EPIZYME INC 0.6%
Value $4.248M Shares 151,000 Share Price $28.13 Est. Cost/Share $28.13 Unrealized @ Report Date —
— SENOMYX INC 0.3%
Value $2.127M Shares 975,610 Share Price $2.18 Est. Cost/Share $2.18 Unrealized @ Report Date —
— TRANZYME INC 0.2%
Value $1.269M Shares 2,700,000 Share Price $0.47 Est. Cost/Share $0.47 Unrealized @ Report Date —
— SAVIENT PHARMACEUTICALS INC 0.0%
Value $228K Shares 1,000,000 Share Price $0.23 Est. Cost/Share $0.23 Unrealized @ Report Date —